Position in BRKR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$243,051
+$90,604 QoQ
Shares Held
6,729
+107.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BRKR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026SIMPLEX TRADING, LLC holds $10,644,342 across 49 Medical Devices names. BRKR ranks #8 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
17,719 | $5,818,388 | |
| 2 | ZBH |
Zimmer Biomet Holdings, Inc.
|
6,887 | $622,722 | |
| 3 | ENOV |
Enovis CORP
|
27,193 | $618,640 | |
| 4 | UFPT |
Ufp Technologies Inc
|
2,376 | $459,993 | |
| 5 | PRCT |
PROCEPT BioRobotics Corp
|
16,725 | $418,292 | |
| 6 | MDT |
Medtronic plc
|
4,575 | $396,423 | |
| 7 | DXCM |
Dexcom Inc
|
5,052 | $317,265 | |
| 8 | BRKR |
Bruker Corp
This page
|
6,729 | $243,051 |
All Filings in BRKR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $243,051 | 6,729 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $152,447 | 3,236 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $443,391 | 13,647 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $540,073 | 12,939 | Shares | Sole | 2025-05-12 | |
| 2024-09-30 | $61,532 | 891 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $30,182 | 473 | Shares | Sole | 2024-07-25 | |
| 2023-03-31 | $29,880 | 379 | Shares | Sole | 2023-04-27 | |
| 2021-12-31 | $609,354 | 7,262 | Shares | Sole | 2022-02-23 | |
| 2021-03-31 | $45,381 | 706 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $53,426 | 987 | Shares | Sole | 2021-02-02 | |
| 2020-06-30 | $51,216 | 1,259 | Shares | Sole | 2020-07-13 | |
| No filing history on record for this holder in this stock. | ||||||